Immature platelet count responses of pediatric patients with immune-mediated thrombotic thrombocytopenic purpura

被引：0
|
作者：
Reeves, Hollie M. [1 ,2 ]
Zhu, Meng-Lei [3 ]
Maitta, Robert W. [4 ,5 ]
机构：
[1] Nationwide Childrens Hosp, Dept Pathol & Lab Med, Columbus, OH USA
[2] Ohio State Univ, Coll Med, Columbus, OH USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY USA
[4] Univ Hosp Cleveland, Med Ctr, Dept Pathol, Cleveland, OH USA
[5] Case Western Reserve Univ, Sch Med, Cleveland Hts, OH USA
来源：
THROMBOSIS RESEARCH | 2024年 / 241卷
关键词：
Platelets; Absolute immature platelet count; Pediatric; Negative feedback; ADAMTS13; Inhibitor; THERAPY;
D O I：
10.1016/j.thromres.2024.109085
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Immature platelet dynamics in management of protracted response to therapy of a young pediatric patient with immune-mediated thrombotic thrombocytopenic purpura
    Maitta, Robert W.
    Reeves, Hollie M.
    Downes, Katharine A.
    He, Xiangrong
    Hackney, Lisa R.
    Ahuja, Sanjay P.
    THROMBOSIS RESEARCH, 2023, 228 : 145 - 147
  • [2] Preemptive cyclosporin A in immune-mediated thrombotic thrombocytopenic purpura
    Comparon, Celine
    Galicier, Lionel
    Rebibou, Jean Michel
    Coppo, Paul
    Benhamou, Ygal
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 110 (02) : 157 - 160
  • [3] Caplacizumab to treat immune-mediated thrombotic thrombocytopenic purpura
    Poullin, P.
    Bornet, C.
    Veyradier, A.
    Coppo, P.
    DRUGS OF TODAY, 2019, 55 (06) : 367 - 376
  • [4] Immature platelet dynamics correlate with ADAMTS13 deficiency and predict therapy response in immune-mediated thrombotic thrombocytopenic purpura
    Zhu, Meng-Lei
    Reeves, Hollie M.
    Maitta, Robert W.
    THROMBOSIS RESEARCH, 2021, 198 : 72 - 78
  • [5] Immature Platelet Dynamics in Immune-Mediated Thrombocytopenic States
    Reeves, Hollie M.
    Maitta, Robert W.
    FRONTIERS IN MEDICINE, 2020, 7
  • [6] Absolute immature platelet count dynamics of thrombotic thrombocytopenic purpura patients with high ADAMTS13 inhibitor
    Gokozan, Hamza N.
    Reeves, Hollie M.
    Maitta, Robert W.
    THROMBOSIS RESEARCH, 2019, 179 : 128 - 131
  • [7] Efficacy and safety of daratumumab in multiresistant immune-mediated thrombotic thrombocytopenic purpura
    Weisinger, Julia
    Bouzid, Raida
    Ranta, Dana
    Woaye-Hune, Pascal
    Cohen-Aubart, Fleur
    Gaible, Clotilde
    Marjanovic, Zora
    Corre, Elise
    Joly, Anne-Christine
    Baylatry, Minh-Tam
    Joly, Berangere S.
    Veyradier, Agnes
    Coppo, Paul
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (05) : 1951 - 1958
  • [8] Treatment of immune-mediated thrombotic thrombocytopenic purpura: A decisive turning point
    Poullin, P.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2021, 28 (04) : 380 - 385
  • [9] Dynamic changes in absolute immature platelet count suggest the presence of a coexisting immune process in the setting of thrombotic thrombocytopenic purpura
    Stefaniuk, Catherine M.
    Reeves, Hollie M.
    Maitta, Robert W.
    TRANSFUSION, 2017, 57 (04) : 913 - 918
  • [10] Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura
    Kangro, Kadri
    Roose, Elien
    Joly, Berangere S.
    Sinkovits, Gyorgy
    Falter, Tanja
    von Auer, Charis
    Rossmann, Heidi
    Reti, Marienn
    Voorberg, Jan
    Prohaszka, Zoltan
    Laemmle, Bernhard
    Coppo, Paul
    Veyradier, Agnes
    De Meyer, Simon F.
    Mannik, Andres
    Vanhoorelbeke, Karen
    BLOOD ADVANCES, 2021, 5 (17) : 3427 - 3435
12345